EP3646851A4 - Anti-aging composition comprising lactic acid bacteria-derived extracellular vesicle - Google Patents

Anti-aging composition comprising lactic acid bacteria-derived extracellular vesicle Download PDF

Info

Publication number
EP3646851A4
EP3646851A4 EP18824818.1A EP18824818A EP3646851A4 EP 3646851 A4 EP3646851 A4 EP 3646851A4 EP 18824818 A EP18824818 A EP 18824818A EP 3646851 A4 EP3646851 A4 EP 3646851A4
Authority
EP
European Patent Office
Prior art keywords
lactic acid
acid bacteria
extracellular vesicle
derived extracellular
aging composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP18824818.1A
Other languages
German (de)
French (fr)
Other versions
EP3646851A2 (en
Inventor
Wanil Kim
Eun-Gyung Cho
Tae Ryong Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amorepacific Corp
Original Assignee
Amorepacific Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amorepacific Corp filed Critical Amorepacific Corp
Publication of EP3646851A2 publication Critical patent/EP3646851A2/en
Publication of EP3646851A4 publication Critical patent/EP3646851A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP18824818.1A 2017-06-29 2018-06-25 Anti-aging composition comprising lactic acid bacteria-derived extracellular vesicle Pending EP3646851A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020170082464A KR102348048B1 (en) 2017-06-29 2017-06-29 Anti-aging composition comprising extracellular vesicles derived from lactic acid bacteria
PCT/KR2018/007166 WO2019004673A2 (en) 2017-06-29 2018-06-25 Anti-aging composition comprising lactic acid bacteria-derived extracellular vesicle

Publications (2)

Publication Number Publication Date
EP3646851A2 EP3646851A2 (en) 2020-05-06
EP3646851A4 true EP3646851A4 (en) 2021-04-07

Family

ID=64742411

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18824818.1A Pending EP3646851A4 (en) 2017-06-29 2018-06-25 Anti-aging composition comprising lactic acid bacteria-derived extracellular vesicle

Country Status (4)

Country Link
EP (1) EP3646851A4 (en)
KR (1) KR102348048B1 (en)
CN (1) CN111225659B (en)
WO (1) WO2019004673A2 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102558281B1 (en) * 2020-03-04 2023-07-25 주식회사 엠디헬스케어 Composition for regulating stem cell function comprising Lactobacillus Bacteria-derived extracellular vesicles as an active ingredient
KR102290979B1 (en) * 2020-03-23 2021-08-20 한국콜마주식회사 Vesicle composition comprising insoluble effective ingredients with improved stability, and cosmetic composition comprising the same
KR102248258B1 (en) * 2020-05-04 2021-05-04 주식회사 바이오에프디엔씨 Composition for skin improvement comprising green tea plant cell-derived exosomes as an active ingredient
KR20220008783A (en) * 2020-07-14 2022-01-21 주식회사 리스큐어바이오사이언시스 Composition for treating brain diseases comprising Pediococcus inopinatus or extracellular vesicle derived therefrom as an active ingredient
KR102376516B1 (en) * 2020-09-08 2022-03-21 주식회사 바이오솔루션 method for producing microbial-derived extracellular vesicle with improved yield and composition for improving skin condition comprising extracellular vesicle produced by the method thereof
KR102430604B1 (en) * 2020-09-08 2022-08-09 주식회사 바이오솔루션 composition for anti-aging comprising extracellular vesicle derived from lactic acid bacteria
WO2022055250A1 (en) * 2020-09-08 2022-03-17 주식회사 바이오솔루션 Method for manufacturing microorganism-derived extracellular vesicles having improved yield, and composition for improving skin condition comprising extracellular vesicles manufactured thereby
KR102253418B1 (en) * 2020-10-08 2021-05-18 (주)지에프씨생명과학 Composition comprising an exosome derived from skin lactic acid bacteria as an active ingredient
CN115305211A (en) * 2021-05-07 2022-11-08 葡萄王生技股份有限公司 Probiotics extracellular exosomes and uses thereof
JP2024522146A (en) * 2021-06-03 2024-06-11 エムディー ヘルスケア インコーポレイテッド Lactobacillus plantarum derived vesicles and their uses
WO2022255746A1 (en) * 2021-06-03 2022-12-08 주식회사 엠디헬스케어 Lactobacillus acidophilus-derived vesicle and use thereof
WO2022255784A1 (en) * 2021-06-03 2022-12-08 주식회사 엠디헬스케어 Lactobacillus rhamnosus-derived vesicle and uses thereof
CN115942945A (en) * 2021-06-03 2023-04-07 Md保健株式会社 Composition for preventing or treating eye diseases, containing extracellular vesicles derived from lactobacillus paracasei
JP2024520165A (en) * 2021-06-07 2024-05-21 エムディー ヘルスケア インコーポレイテッド Composition for preventing or treating inflammatory disease or cancer, comprising vesicles derived from Leuconostoc bacteria
KR20230008997A (en) * 2021-07-08 2023-01-17 주식회사 래디안 Cosmetic composition comprising extracellular vesicles and lysate derived from yeast
KR102596743B1 (en) * 2021-10-18 2023-11-02 (주) 네이처인트로 Hybrid liposome conjugated extracellular vesicles derived lactic acid bacteria and coenzyme q10 liposome and the use thereof
CN115161254B (en) * 2022-03-11 2024-09-27 中国农业大学 Method for improving yield of extracellular vesicles of lactic acid bacteria
CN115161215A (en) * 2022-03-11 2022-10-11 中国农业大学 Fermentation method of bifidobacterium and application thereof
WO2023229034A1 (en) * 2022-05-27 2023-11-30 アサヒグループホールディングス株式会社 Fpr2 agonist containing outer membrane vesicles derived from lactic acid bacterium
KR20240030480A (en) 2022-08-31 2024-03-07 주식회사 래디안 Composition for improving skin condition comprising probiotics extracellular vesicles and preparation method thereof
KR102485314B1 (en) * 2022-09-22 2023-01-09 주식회사 에이바이오머티리얼즈 Cosmetic composition comprising fermented shea butter and exosome derived from lactic acid bacteria
CN116948921B (en) * 2023-09-19 2023-12-26 黑龙江省科学院微生物研究所 Lactobacillus plantarum and application of exosome thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110113026A (en) * 2010-04-08 2011-10-14 경희대학교 산학협력단 Composition for inhibiting skin aging
WO2016144139A2 (en) * 2015-03-11 2016-09-15 주식회사 엠디헬스케어 Composition for preventing or treating inflammatory diseases, comprising lactic acid bacteria-derived extracellular vesicles as active ingredients
KR20160110232A (en) * 2015-03-11 2016-09-21 주식회사 엠디헬스케어 Composition for Prevention or Treatment of Inflammatory disease Comprising Extracellular Vesicles Derived from Lactic acid bacteria
WO2017057882A1 (en) * 2015-09-30 2017-04-06 (주)아모레퍼시픽 Composition for preventing hair loss or promoting hair growth comprising extracellular follicle derived from lactic acid bacteria

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2912916B1 (en) * 2007-02-26 2009-05-22 Oreal COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A CELL CULTURE MEDIUM
WO2011027956A2 (en) * 2009-09-04 2011-03-10 주식회사이언메딕스 Extracellular vesicles derived from gram-positive bacteria, and disease model using same
KR20110082480A (en) * 2010-01-11 2011-07-19 포항공과대학교 산학협력단 Composition comprising extracellular vesicles derived from mammals, and use thereof
KR101784940B1 (en) * 2010-08-31 2017-10-12 (주)아모레퍼시픽 Cosmetic composition for improving skin elasticity
KR101492003B1 (en) * 2013-04-29 2015-02-23 주식회사한국야쿠르트 Probiotics of Lactobacillus plantarum HY7714 for skin wrinkle inhibitory and moisurizing effects and use of thereof as skin anti-wrinkle or moisturizing products
KR101716428B1 (en) * 2015-03-24 2017-03-15 주식회사 코리아나화장품 Cosmetic composition containing fermentative extract of hippocampus coronatus as active ingredient
KR102623439B1 (en) * 2016-01-29 2024-01-11 (주)아모레퍼시픽 Anti-fungal composition comprising lactobacillus plantarum

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110113026A (en) * 2010-04-08 2011-10-14 경희대학교 산학협력단 Composition for inhibiting skin aging
WO2016144139A2 (en) * 2015-03-11 2016-09-15 주식회사 엠디헬스케어 Composition for preventing or treating inflammatory diseases, comprising lactic acid bacteria-derived extracellular vesicles as active ingredients
KR20160110232A (en) * 2015-03-11 2016-09-21 주식회사 엠디헬스케어 Composition for Prevention or Treatment of Inflammatory disease Comprising Extracellular Vesicles Derived from Lactic acid bacteria
EP3269378A2 (en) * 2015-03-11 2018-01-17 MD Healthcare Inc. Composition for preventing or treating inflammatory diseases, comprising lactic acid bacteria-derived extracellular vesicles as active ingredients
WO2017057882A1 (en) * 2015-09-30 2017-04-06 (주)아모레퍼시픽 Composition for preventing hair loss or promoting hair growth comprising extracellular follicle derived from lactic acid bacteria
EP3357500A1 (en) * 2015-09-30 2018-08-08 Amorepacific Corporation Composition for preventing hair loss or promoting hair growth comprising extracellular follicle derived from lactic acid bacteria

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHUNG H Y ET AL: "Molecular inflammation: Underpinnings of aging and age-related diseases", AGEING RESEARCH REVIEWS, ELSEVIER, AMSTERDAM, NL, vol. 8, no. 1, 1 January 2009 (2009-01-01), pages 18 - 30, XP025837672, ISSN: 1568-1637, [retrieved on 20080718], DOI: 10.1016/J.ARR.2008.07.002 *
DAGNELIE MARIE-ANGE ET AL: "Bacterial extracellular vesicles: A new way to decipher host-microbiota communications in inflammatory dermatoses", EXPERIMENTAL DERMATOLOGY, vol. 29, no. 1, 12 November 2019 (2019-11-12), COPENHAGEN; DK, pages 22 - 28, XP055774752, ISSN: 0906-6705, Retrieved from the Internet <URL:https://onlinelibrary.wiley.com/doi/full-xml/10.1111/exd.14050> DOI: 10.1111/exd.14050 *
See also references of WO2019004673A2 *

Also Published As

Publication number Publication date
KR20190002079A (en) 2019-01-08
CN111225659B (en) 2023-04-28
EP3646851A2 (en) 2020-05-06
KR102348048B1 (en) 2022-01-10
WO2019004673A3 (en) 2019-02-21
WO2019004673A2 (en) 2019-01-03
CN111225659A (en) 2020-06-02

Similar Documents

Publication Publication Date Title
EP3646851A4 (en) Anti-aging composition comprising lactic acid bacteria-derived extracellular vesicle
HK1251147A1 (en) Composition for preventing hair loss or promoting hair growth comprising extracellular follicle derived from lactic acid bacteria
EP3269378A4 (en) Composition for preventing or treating inflammatory diseases, comprising lactic acid bacteria-derived extracellular vesicles as active ingredients
EP3259592A4 (en) Novel skin remodeling strategy
EP3182985A4 (en) Fibroin-derived protein composition
EP3368003A4 (en) Cosmetic composition comprising polyurethane
EP3362038A4 (en) Cosmetic composition having probiotic bacteria
EP3431082A4 (en) Anti-aging composition
EP3185888A4 (en) Extracellular matrix compositions
EP3177657A4 (en) Polyurethane urea solutions for nail varnish compositions
EP3558050A4 (en) Fresh cosmetic composition delivery system
EP3292857A4 (en) Cosmetic composition
EP3431081A4 (en) Anti-aging composition
EP3191188A4 (en) Compositions for keratin fibers
EP3616683A4 (en) Cosmetic composition
EP3704757A4 (en) Electrolyte composition
EP3246014A4 (en) Toothpaste composition
EP3705566A4 (en) Immunomodulatory composition comprising lactobacillus-derived extracellular vesicles
EP3384549A4 (en) Sodium-ion electrolyte composition
EP3731803A4 (en) Composition for conditioning keratin fibers
EP3118260A4 (en) Polylactic acid composition
EP3453718A4 (en) Lactic acid bacteria-derived protein and preparation method therefor
EP3662907A4 (en) Anti-aging or skin-regenerating composition comprising piperonylic acid as effective ingredient
SG11201701577WA (en) Lactic acid bacteria-containing composition
EP3165599A4 (en) Novel lactic acid bacterium and composition including said lactic acid bacterium

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20191205

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20210305

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 8/14 20060101ALI20210301BHEP

Ipc: A61K 8/99 20170101AFI20210301BHEP

Ipc: A61Q 17/04 20060101ALI20210301BHEP

Ipc: A61Q 19/08 20060101ALI20210301BHEP

Ipc: A61Q 19/00 20060101ALI20210301BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230210